About Transcription factor Sp7
Transcription factor Sp7 (SP7) is a protein
from Homo sapiens identified by UniProt accession
Q8TDD2, 431 residues long.
MolForge cross-references it against 0 known binders and
196 disease associations.
Target properties
| Protein name | Transcription factor Sp7 |
| UniProt accession | Q8TDD2 |
| Gene | SP7 |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (196)
Diseases linked to this target (Open Targets).
- osteogenesis imperfecta · score 0.57
- Skeletal dysplasia · score 0.37
- craniodiaphyseal dysplasia · score 0.37
- osteogenesis imperfecta type 4 · score 0.37
- heel bone mineral density · score 0.33
- alkaline phosphatase measurement · score 0.31
- bone density · score 0.28
- joint disease · score 0.17
- monocyte percentage of leukocytes · score 0.16
- bone quantitative ultrasound measurement · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TDD2-F1 | alphafold | PREDICTED | 51.81 | — |
Amino-acid sequence (431 residues)
MASSLLEEEV HYGSSPLAML TAACSKFGGS SPLRDSTTLG KAGTKKPYSV GSDLSASKTM GDAYPAPFTS TNGLLSPAGS PPAPTSGYAN DYPPFSHSFP GPTGTQDPGL LVPKGHSSSD CLPSVYTSLD MTHPYGSWYK AGIHAGISPG PGNTPTPWWD MHPGGNWLGG GQGQGDGLQG TLPTGPAQPP LNPQLPTYPS DFAPLNPAPY PAPHLLQPGP QHVLPQDVYK PKAVGNSGQL EGSGGAKPPR GASTGGSGGY GGSGAGRSSC DCPNCQELER LGAAAAGLRK KPIHSCHIPG CGKVYGKASH LKAHLRWHTG ERPFVCNWLF CGKRFTRSDE LERHVRTHTR EKKFTCLLCS KRFTRSDHLS KHQRTHGEPG PGPPPSGPKE LGEGRSTGEE EASQTPRPSA SPATPEKAPG GSPEQSNLLE I
Explore Transcription factor Sp7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets